/products/cell-line/jurkat-btla-signaling-cell-line-93-1112c19
/products/cell-line/u2os-hvem-ligand-cell-line-93-1116c3
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immunostimulatory checkpoint receptors have pr...
/tools-resources/document-resource-library/documents/pegs-2017-novel,-improved-cell-based-assays-to-enable-immunotherapy-drug-development-for-checkpoin
4/28/2017 9:04:39 PM
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immunostimulatory checkpoint receptors have pr...
/tools-resources/document-resource-library/documents/bebpa-usa-2017-novel,-improved-cell-based-assays-to-enable-immunotherapy-drug-development-for-chec
3/7/2017 9:35:33 PM
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immunostimulatory checkpoint receptors have proved...
/tools-resources/document-resource-library/documents/ici-2017-novel,-improved-cell-based-assays-to-enable-immunotherapy-drug-development-for-checkpoint
3/13/2017 10:01:34 PM
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have prove...
/tools-resources/document-resource-library/documents/dot-2017-novel,-improved-cell-based-assays-to-enable-immunotherapy-drug-development-for-checkpoint
9/22/2017 6:37:39 PM
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have prove...
/tools-resources/document-resource-library/documents/elrig-2017-novel,-improved-cell-based-assays-to-enable-immunotherapy-drug-development-for-checkpoi
9/26/2017 11:24:43 PM
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have prov...
/tools-resources/document-resource-library/documents/bebpa-2017-checkpoint-receptor-poster
9/27/2017 5:50:09 PM